Neurokinin a is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects

Thorax

Volumn 53, Issue 5, 1998, Pages 357-362

  Heaney, L G ^a,b,c   Cross, L J M ^b   McGarvey, L P A ^a   Buchanan, K D ^b   Ennis, M ^b   Shaw, C ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Bronchoalveolar lavage; Neurokinin A; Substance P

Indexed keywords

NEUROKININ A;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREACTIVITY; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

EID: 0031811896     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.5.357     Document Type: Article

References (26)

1. Springall DR, Polak JM. Localization of peptides in the lung. Ann NY Acad Sci 1991;629:288-304.
2. Martling CR. Sensory nerves containing tachykinins and CGRP in the lower airways. Functional implications for bronchoconstriction, vasodilation and protein extravasarion. Acta Physiol Scand 1987;Suppl 563:1-57.
3. Joos GF, Pauwels RA. The bronchoconstrictor effect of sensory neuropeptides in man. Ann NY Acad Sci 1991;629: 371-82.
4. Nieber K, Baumgarten CR, Rathsack R, et al. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646-52.
5. Nieber K, Baumgarten C, Rathsack R, et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin Exp Allergy 1993;23:69-71.
6. Hazbun ME, Hamilton R, Holian A, et al. Ozone induced increases in substance P and 8-epi-prostaglandin F in airways of human subjects. Am J Respir Cell Mol Biol 1993;9: 568-72.
7. American Thoracic Society. Committee on Diagnostic Standards, Definitions and Classification of Chronic Bronchitis, Asthma and Pulmonary Emphysema. Am Rev Respir Dis 1962;85:762.
8. Cockroft DW, Killian DN, Melon JJA, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-40.
9. Maule AG, Shaw C, Halton DW, et al. Tachykinin immunoreactivity in the parisitic flatworm Diclidophora merlangi and its fish host the whiting (Merlangius merlangus): radioimmunoassay and chromatographic characterisation using region-specific substance P and neurokinin A antisera. Comp Biochem Physiol 1989;94:535-41.
10. Shaw C, Foy WL, Johnston CF, et al. Identification and characterisation of multiple tachykinin immunoreactivities in bovine retina: evidence for the presence of a putative oxidative inactivation system for substance P. J Neurochem 1989;53:1547-54.
11. Abdulah AR. The measurement of substance P by radioimmunoassay. PhD Thesis, Belfast , 1984.
12. Takeyama M, Nagai S, Mori K, et al. Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 1996;13:33-7.
13. Wershil BK, Turck CW, Sreedharan SP, et al. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukaemic cells. Cell Immunol 1993;151:369-78.
14. Simon C, Portalier P, Chamoin MC, et al. Substance P like-immunoreactivity release from enterochromaffin cells of rat caecum mucosa. Inhibition by serotonin and calcium-free medium. Neurochem Int 1992;20:529-36.
15. Fujishima H, Takeyama M, Takuchi T, et al. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy 1997;27:372-8.
16. Nawa H, Kotani H, Nakanishi S. Tissue specific generation of two preprotachykinin mRNAs from one gene through alternative RNA splicing. Nature 1984;312:729-34.
17. Kotani H, Hoshimaru M, Nawa H, et al. Sequence analysis of cloned cDNA for rat substance P precursor. Biochem Biophys Res Commun 1986;139:1040-6.
18. Tatemoto K, Lundberg JM, Jornvall H, et al. Neuropeptide K: isolation, structure and biological activities of a novel brain peptide. Biochem Biophys Res Commun 1985;128: 947-53.
19. Kage R, McGregor GP, Thim L, et al. Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J Neurochem 1988; 50:1412-7.
20. Bakhle YS, Bell C. Neurokinin A and substance P vary independently in different regions of rat sensory neurons. Neuropeptides 1994;28:237-41.
21. Advenier C, Naline E, Toty L, et al. Effects on the isolated human bronchus of SR 48968, a potent and selective non-peptide antagonist of the neurokinin A (NK2) receptors. Am Rev Respir Dis 1992;146:1177-81.
22. 1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 1995;269:309-17.
23. Joos G, Pauwels R, van der Straeten M. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 1987;42:779-83.
24. Crimi N, Palermo F, Oliveri R, et al. Protection of nedocromil sodium on bronchoconstriction induced by inhaled neurokinin A (NKA) in asthmatic patients. Clin Exp Allergy 1992;22:75-81.
25. Crimi N, Palermo F, Oliveri R, et al. Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects. Clin Allergy 1988;18:375-82.
26. Ben-Jebria A, Marthan R, Rossetti M, et al. Effect of passive sensitisation on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br J Pharmacol 1993;109:131-6.